HCA Healthcare Inc. (HCA) Stock Analysis 2026
BriMind AI Score
ProprietaryScore based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.
AI scores and price targets are for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results. Always conduct your own research before making investment decisions. Full Disclaimer →
About HCA Healthcare Inc.
HCA Healthcare is the largest for-profit hospital operator in the United States, operating 186 hospitals and 2,400+ ambulatory sites across 20 states and the UK. HCA's scale gives it negotiating leverage with insurance payers, purchasing efficiency for supplies, and the ability to invest in technology and specialized services that smaller hospitals cannot afford. The company focuses on high-acuity, high-margin services and has a growing ambulatory (outpatient surgery and urgent care) network alongside its inpatient hospitals.
How HCA Healthcare Makes Money
HCA earns from hospital services (inpatient and outpatient care billed to Medicare, Medicaid, and commercial insurers). Commercial insurance reimbursements are significantly higher than government rates, making commercial patient mix crucial to profitability. HCA's hospitals are concentrated in high-growth Sun Belt markets (Texas, Florida, Tennessee) with favorable population demographics. Outpatient surgery centers, urgent care, and physician practices are growing revenue contributors.
HCA Healthcare Revenue & Profitability Breakdown
This chart shows how HCA Healthcare's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.
Key Financial Metrics
HCA Healthcare Inc. trades at a trailing P/E of 14.01x, generates $3.74B in free cash flow, hasn't disclosed a debt/equity ratio, and converts shareholder equity into profit at a 13631.7% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.
Wall Street Analyst Consensus
Wall Street analysts covering HCA Healthcare Inc. currently haven't converged on a clear consensus rating, with a mean 12-month price target of $451.48 (+5.6% vs the current price). Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.
Technical Price Signals
HCA is currently in a short-term uptrend, trading above its 50-day average of $401.06 and below its 200-day average of $453.33. Moving averages smooth out day-to-day volatility to reveal the underlying trend — a Golden Cross (50MA crosses above 200MA) is a classic bullish signal, a Death Cross is bearish, though both are lagging indicators that confirm trends rather than predict them.
HCA Investment Case: Bull vs Bear
HCA's investment case breaks down into 4 bull points and 4 bear points below. The bull case outlines the key reasons the stock could outperform — competitive advantages, growth catalysts, and market tailwinds. The bear case highlights the most significant risks. A strong bull case with manageable bear risks typically makes for a more compelling investment.
Bull Case (Reasons to Buy)
- Sun Belt demographic tailwind — Texas and Florida are among the fastest-growing states in the US, directly expanding HCA's hospital patient volumes.
- Commercial insurance mix is superior to most hospital systems — HCA's markets attract employed, commercially insured patients rather than Medicaid-heavy urban populations.
- Ambulatory surgery center expansion moves high-margin elective procedures to lower-cost outpatient settings, improving profitability and patient satisfaction.
- Hospital supply/demand imbalance in Sun Belt markets — population growth outpaces hospital capacity additions, maintaining pricing leverage with insurers.
Bear Case (Key Risks)
- Healthcare labor inflation (nurses, physicians) has been severe and persistent — staffing costs are HCA's largest expense and remain elevated from pandemic-era levels.
- Government reimbursement rate increases (Medicare, Medicaid) often lag medical cost inflation, compressing margins on government-payer patients.
- Regulatory risk: potential changes to Medicaid funding (DSHA waivers, managed Medicaid) or Medicare Advantage growth could alter reimbursement dynamics.
- HCA carries significant debt from share buybacks and hospital acquisitions, limiting balance sheet flexibility in downturns.
What to Watch: HCA Key Metrics
HCA Stock — Frequently Asked Questions
Compare HCA with Peers
Unlock the Full HCA Analysis
Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.